MetaCap

InspireMD (NSPR) vs Picard Medical (PMI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

InspireMD (NSPR) has outperformed Picard Medical (PMI) over the past year, losing 72.0% versus a loss of 94.0%. InspireMD is the larger company by market cap ($29.2 million vs $18.1 million), about 1.6 times the size. InspireMD converts more of its revenue into profit, with a net margin of -543.3% versus -546.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NSPR-72.02%PMI-94.02%
+71%-17%-105%
Nov 21, 20251 yearNov 20, 2026
NSPR-77.87%PMI-97.04%
+123%+7%-109%
Aug 25, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NSPR versus PMI key metrics
MetricNSPRPMI
Share price$0.54$6.79
Market cap$29.23M$18.07M
1-day change-12.97%+7.78%
YTD return-69.66%-92.24%
1-year return-72.02%-94.02%
5-year return-85.12%—
P/E ratio (TTM)—3.04
EPS (TTM)$-0.57$2.23
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$8.98M$4.94M
Revenue growth (YoY)+28.11%+12.50%
Net income (latest FY)$-48.79M$-27.00M
Gross margin29.50%-4.13%
Operating margin-552.56%-268.36%
Net margin-543.33%-546.60%
52-week high$2.17$208.00
52-week low$0.43$2.65
Distance from 52-week high-75.12%-96.74%
Analyst consensusnone—
Avg. price target upside+516.67%—
Average volume234.68K1.45M
Shares outstanding54.13M2.66M
Employees12775
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NSPR has outperformed PMI by 22.0 percentage points over the past year.
  • InspireMD grew revenue faster in its latest fiscal year (+28.11% vs +12.50%).

About InspireMD

NSPR stock →

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.

Health Care · Medical/Dental Instruments · 127 employees

About Picard Medical

PMI stock →

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

Health Care · Medical/Dental Instruments · 75 employees

NSPR vs PMI FAQ

Which is bigger, InspireMD or Picard Medical?

InspireMD (NSPR) is larger, with a market capitalization of $29.23M compared with $18.07M for Picard Medical (PMI).

Which stock has performed better over the past year, NSPR or PMI?

NSPR returned -72.02% over the past 12 months, compared with -94.02% for PMI (price return, excluding dividends). Past performance does not predict future results.

Are InspireMD and Picard Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons